Schedule 13G ownership disclosure

Calliditas Therapeutics AB

Security class unavailable

Event date: 2022-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
0
Percent of class
0.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001547676-23-000002
Form type
SC 13G
Filer
Calliditas Therapeutics AB
CIK
CIK 1795579
Filed
Jan 26, 2023
Reporting period
Dec 31, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub